Post by OncoDaily

Our new OncoDaily Research & Intelligence newsletter is live: “10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition.” A concise look at late-stage agents that could soon redefine oncology care - check it out.